Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTang, Yi-
dc.contributor.authorWang, Yinzhen-
dc.contributor.authorXu, Xiaoping-
dc.contributor.authorTu, Laura Yan-
dc.contributor.authorHuang, Pei-
dc.contributor.authorYang, Xiaoyan-
dc.contributor.authorLi, Lihua-
dc.contributor.authorWu, Juan-
dc.contributor.authorZhang, Yan-
dc.contributor.authorFu, Qinghua-
dc.contributor.authorYu, Yingli-
dc.contributor.authorZheng, Zhaofen-
dc.contributor.authorSong, Lixia-
dc.contributor.authorZhang, Yi-
dc.identifier.citationBMC cardiovascular disorders 2021; 21(1): 511en
dc.description.abstractThe prognostic value of human epididymis protein 4 (HE4) in patients with ischemic cardiomyopathy (ICM) is unknown. A total of 103 patients with ICM were prospectively enrolled in this study from Hunan Provincial People's Hospital between February 2019 and June 2019. All patients were tested for HE4 levels at baseline and follow-up. Endpoints of the study included cardiovascular death and heart failure-related hospitalization. A total of 96 patients with ICM were included for analysis. After a mean follow-up period of 263 (153-313) days, cardiovascular events were observed in 45 patients. Serum HE4 levels in patients with events were significantly higher than those in patients without events [188.70 (113.35-326.82) pmol/L versus 92.90 (61.50-123.20) pmol/L, P < 0.001]. Multivariate Cox regression analysis revealed that HE4 [χ2: 9.602, hazard ratio (HR): 1.003, 95% confidence interval (CI): 1.001-1.005, P = 0.002] and age [χ2: 4.55, HR: 1.044, 95% CI: 1.003-1.085, P = 0.033] were independent predictors of events. After adjusting for age and sex, the risk of events in patients with HE4 > 100.2 pmol/L was higher than that in patients with HE4 ≤ 100.2 pmol/L [HR: 3.372, 95% CI: 1.409-8.065, P < 0.001]. HE4 is an independent predictor of cardiovascular death and heart failure-related rehospitalization in patients with ICM.en
dc.subjectHuman epididymis protein 4en
dc.subjectIschemic cardiomyopathyen
dc.titleHuman epididymis protein 4: a novel predictor of ischemic cardiomyopathy.en
dc.typeJournal Articleen
dc.identifier.journaltitleBMC Cardiovascular Disordersen
dc.identifier.affiliationGeneral Medicineen
dc.identifier.affiliationDepartment of Cardiology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Clinical Medicine Research Center of Heart Failure of Hunan Province, Hunan Normal University, Changsha, 410005, Chinaen
dc.identifier.affiliationDepartment of Gastroenterology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal University, Changsha, 410005, Chinaen
dc.identifier.affiliationInstitute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, Chinaen
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Sep 29, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.